AN2 Therapeutics (ANTX) Treasury Shares (2021)

AN2 Therapeutics (ANTX) has reported Treasury Shares for 3 consecutive years, with $856160.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Treasury Shares rose 65.76% year-over-year to $856160.0; the TTM figure through Dec 2025 stood at $856160.0 (up 65.76% YoY), while the FY2025 annual figure was $856160.0, up 65.76% from the prior year.
• Treasury Shares retreated to $856160.0 in Q4 2025 per ANTX's latest filing, from $927468.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $11.4 million in Q1 2021 and bottomed at $458246.0 in Q1 2024.
• Historically, Treasury Shares has averaged $4.6 million across 3 years, with a median of $923664.0 in 2025.
• On a YoY basis, Treasury Shares climbed as much as 101.57% in 2025 and fell as far as 48.46% in 2025.
• AN2 Therapeutics' Treasury Shares stood at $11.4 million in 2021, then slumped by 95.47% to $516511.0 in 2024, then surged by 65.76% to $856160.0 in 2025.
• Business Quant data shows ANTX's Treasury Shares at $856160.0 in Q4 2025, $927468.0 in Q2 2025, and $923664.0 in Q1 2025.